Form D — Gut-Brain-Axis Therapeutics Inc.
0001996678-25-000002 · filed Nov 6, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(c)
- Reported offering amount
- $20,000,000
- Reported amount sold
- $1,965,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Gut-Brain-Axis Therapeutics Inc.
- CIK
- 1996678
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 1340 E VINEDO LANE
TEMPE, Arizona 85284 - Phone
- (480) 818-0741
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James B. Adams · Executive OfficerTempe, Arizona Find on LinkedIn ↗
-
Alexander Khoruts · DirectorTempe, Arizona Find on LinkedIn ↗
-
Rosa Krajmalnik-Brown · DirectorTempe, Arizona Find on LinkedIn ↗
-
Michael J. Sadowsky · DirectorTempe, Arizona Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗